Related Experiment Video
Updated: Mar 27, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Leukemia inhibitory factor (LIF) withdrawal activates mTOR signaling pathway in mouse embryonic stem cells through
M Y Cherepkova1, G S Sineva1, V A Pospelov1
1Laboratory of Molecular Mechanisms Cell Differentiation, Institute of Cytology, Russian Academy of Sciences, St. Petersburg, Russia.
Abstract:
Leukemia inhibitory factor (LIF) is indispensable to maintain the pluripotent state of mouse embryonic stem cells (ESCs), but the mechanisms underlying the role of LIF/STAT3 pathway are yet poorly understood. Here we first showed that the LIF/STAT3-regulated signaling pathway contributes to the maintenance of self-renewal and pluripotency of mouse ESCs by suppressing mTOR (mammalian target of rapamycin), which is necessary for early differentiation. When LIF is withdrawn from culture medium, the mTOR activity rapidly increases as detected by phosphorylation of its targets - ribosomal protein S6 and translation factor 4EBP1. In turn, suppression of STAT3 phosphorylation on Tyr-705 by a specific small molecule WP1066 also activates phosphorylation of the mTOR target S6 ribosomal protein. LIF removal strongly activates ERK activity indicating that ERK can be involved in either direct phosphorylation of mTOR or phosphorylation of an upstream negative regulator of mTOR - TSC1/TSC2 proteins. According to western blotting data, LIF withdrawal leads to phosphorylation of TSC2 protein thereby relieving its negative effect on mTOR activity. mTOR activation is accompanied by a decrease of pluripotent gene expression Oct-4, Nanog, Sox2 and by an augmentation of fgf5 gene expression - a marker of post-implantation epiblast. Together, these data indicate that LIF-depleted mouse ESCs undergo a transition from the LIF/STAT3-supported pluripotent state to the FGFR/ERK-committed primed-like state with expression of early differentiation markers mediated through activation of mTOR signaling.
Insights
Leukemia inhibitory factor (LIF) maintains mouse embryonic stem cell (ESC) pluripotency by suppressing mTOR signaling via the STAT3 pathway. LIF withdrawal activates mTOR and ERK, promoting differentiation.
Area of Science:
- Stem cell biology
- Molecular signaling pathways
- Cellular differentiation
Background:
- Leukemia inhibitory factor (LIF) is crucial for maintaining the pluripotency of mouse embryonic stem cells (ESCs).
- The precise molecular mechanisms by which the LIF/STAT3 pathway regulates ESC self-renewal and pluripotency remain incompletely understood.
- Mammalian target of rapamycin (mTOR) signaling is implicated in cellular differentiation processes.
Purpose of the Study:
- To elucidate the role of the LIF/STAT3 signaling pathway in maintaining mouse ESC pluripotency.
- To investigate the relationship between LIF/STAT3 signaling and mTOR activity in ESCs.
- To understand the molecular events leading to ESC differentiation upon LIF withdrawal.
Main Methods:
- Western blotting to detect protein phosphorylation (e.g., S6, 4EBP1, STAT3, ERK, TSC2).
- Treatment of ESCs with LIF, LIF withdrawal, and specific small molecule inhibitors (e.g., WP1066).
- Quantitative analysis of gene expression for pluripotency markers (Oct-4, Nanog, Sox2) and differentiation markers (fgf5).
Main Results:
- LIF withdrawal rapidly increased mTOR activity, evidenced by increased phosphorylation of its targets S6 and 4EBP1.
- Suppression of STAT3 phosphorylation also led to mTOR activation.
- LIF withdrawal activated ERK signaling and caused phosphorylation of TSC2, relieving its inhibition on mTOR.
- mTOR activation correlated with decreased expression of pluripotency genes (Oct-4, Nanog, Sox2) and increased expression of the differentiation marker fgf5.
Conclusions:
- The LIF/STAT3 pathway maintains mouse ESC pluripotency by suppressing mTOR signaling.
- LIF withdrawal triggers a transition from a pluripotent state to a primed-like state via mTOR activation and ERK signaling.
- This transition involves the downregulation of key pluripotency factors and upregulation of early differentiation markers.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
PI3K/mTOR/AKT Signaling Pathway
MAPK Signaling Cascades
Mitogens and the Cell Cycle
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

